LG Life Science’s partnership for the ‘Humira biosimilar’ with Mochida in Japan
On the 15th, LG Life Science Ltd. (CEO: Il-jae Jung) announced that it made a partnership with a Japanese company, Mochida, to develop and sell the Humira biosimilar, a global drug for autoimmune disease.
Through the partnership, Mochida will secure exclusive rights in Japan to develop and sell ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
